nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—Jaundice cholestatic—Progesterone—uterine cancer	0.0276	0.0279	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Medroxyprogesterone Acetate—uterine cancer	0.025	0.0252	CcSEcCtD
Methocarbamol—Lightheadedness—Progesterone—uterine cancer	0.0217	0.0219	CcSEcCtD
Methocarbamol—Thrombophlebitis—Progesterone—uterine cancer	0.0203	0.0205	CcSEcCtD
Methocarbamol—Nasal congestion—Progesterone—uterine cancer	0.0193	0.0195	CcSEcCtD
Methocarbamol—Injury—Progesterone—uterine cancer	0.0192	0.0193	CcSEcCtD
Methocarbamol—Thrombophlebitis—Medroxyprogesterone Acetate—uterine cancer	0.0184	0.0186	CcSEcCtD
Methocarbamol—Diplopia—Progesterone—uterine cancer	0.0176	0.0178	CcSEcCtD
Methocarbamol—Amnesia—Medroxyprogesterone Acetate—uterine cancer	0.017	0.0171	CcSEcCtD
Methocarbamol—Pain—Carboplatin—uterine cancer	0.0141	0.0142	CcSEcCtD
Methocarbamol—Drowsiness—Progesterone—uterine cancer	0.0136	0.0137	CcSEcCtD
Methocarbamol—Jaundice—Progesterone—uterine cancer	0.0132	0.0133	CcSEcCtD
Methocarbamol—Conjunctivitis—Progesterone—uterine cancer	0.0132	0.0133	CcSEcCtD
Methocarbamol—Body temperature increased—Carboplatin—uterine cancer	0.013	0.0131	CcSEcCtD
Methocarbamol—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.0123	0.0124	CcSEcCtD
Methocarbamol—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.012	0.0121	CcSEcCtD
Methocarbamol—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.0112	0.0113	CcSEcCtD
Methocarbamol—Vision blurred—Progesterone—uterine cancer	0.00999	0.0101	CcSEcCtD
Methocarbamol—Nystagmus—Epirubicin—uterine cancer	0.00974	0.00983	CcSEcCtD
Methocarbamol—Angioedema—Progesterone—uterine cancer	0.00969	0.00978	CcSEcCtD
Methocarbamol—Vertigo—Progesterone—uterine cancer	0.00953	0.00962	CcSEcCtD
Methocarbamol—Syncope—Progesterone—uterine cancer	0.00951	0.0096	CcSEcCtD
Methocarbamol—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00941	0.0095	CcSEcCtD
Methocarbamol—Loss of consciousness—Progesterone—uterine cancer	0.00932	0.00941	CcSEcCtD
Methocarbamol—Carvedilol—VEGFA—uterine cancer	0.0093	1	CrCbGaD
Methocarbamol—Convulsion—Progesterone—uterine cancer	0.00919	0.00927	CcSEcCtD
Methocarbamol—Nystagmus—Doxorubicin—uterine cancer	0.00901	0.00909	CcSEcCtD
Methocarbamol—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00878	0.00886	CcSEcCtD
Methocarbamol—Confusional state—Progesterone—uterine cancer	0.00873	0.00881	CcSEcCtD
Methocarbamol—Anaphylactic shock—Progesterone—uterine cancer	0.00865	0.00873	CcSEcCtD
Methocarbamol—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00863	0.00871	CcSEcCtD
Methocarbamol—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00862	0.0087	CcSEcCtD
Methocarbamol—Shock—Progesterone—uterine cancer	0.00851	0.00859	CcSEcCtD
Methocarbamol—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00844	0.00852	CcSEcCtD
Methocarbamol—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00832	0.0084	CcSEcCtD
Methocarbamol—Hypotension—Progesterone—uterine cancer	0.00809	0.00816	CcSEcCtD
Methocarbamol—Flushing—Dactinomycin—uterine cancer	0.00799	0.00806	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Epirubicin—uterine cancer	0.00792	0.00799	CcSEcCtD
Methocarbamol—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00791	0.00798	CcSEcCtD
Methocarbamol—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00784	0.00792	CcSEcCtD
Methocarbamol—Insomnia—Progesterone—uterine cancer	0.00783	0.0079	CcSEcCtD
Methocarbamol—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00771	0.00779	CcSEcCtD
Methocarbamol—Somnolence—Progesterone—uterine cancer	0.00769	0.00777	CcSEcCtD
Methocarbamol—Dyspepsia—Progesterone—uterine cancer	0.00762	0.00769	CcSEcCtD
Methocarbamol—Pain—Progesterone—uterine cancer	0.0074	0.00747	CcSEcCtD
Methocarbamol—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00733	0.0074	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Doxorubicin—uterine cancer	0.00732	0.00739	CcSEcCtD
Methocarbamol—Feeling abnormal—Progesterone—uterine cancer	0.00713	0.0072	CcSEcCtD
Methocarbamol—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00709	0.00716	CcSEcCtD
Methocarbamol—Coordination abnormal—Epirubicin—uterine cancer	0.00708	0.00715	CcSEcCtD
Methocarbamol—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00697	0.00704	CcSEcCtD
Methocarbamol—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.0069	0.00697	CcSEcCtD
Methocarbamol—Urticaria—Progesterone—uterine cancer	0.00687	0.00694	CcSEcCtD
Methocarbamol—Body temperature increased—Progesterone—uterine cancer	0.00684	0.00691	CcSEcCtD
Methocarbamol—Jaundice—Etoposide—uterine cancer	0.00677	0.00683	CcSEcCtD
Methocarbamol—Leukopenia—Dactinomycin—uterine cancer	0.00671	0.00677	CcSEcCtD
Methocarbamol—Coordination abnormal—Doxorubicin—uterine cancer	0.00655	0.00661	CcSEcCtD
Methocarbamol—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00646	0.00652	CcSEcCtD
Methocarbamol—Hypersensitivity—Progesterone—uterine cancer	0.00638	0.00644	CcSEcCtD
Methocarbamol—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00623	0.00629	CcSEcCtD
Methocarbamol—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.0062	0.00626	CcSEcCtD
Methocarbamol—Pruritus—Progesterone—uterine cancer	0.00612	0.00618	CcSEcCtD
Methocarbamol—Thrombophlebitis—Epirubicin—uterine cancer	0.00583	0.00589	CcSEcCtD
Methocarbamol—Flushing—Etoposide—uterine cancer	0.00578	0.00584	CcSEcCtD
Methocarbamol—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00578	0.00583	CcSEcCtD
Methocarbamol—Dizziness—Progesterone—uterine cancer	0.00572	0.00578	CcSEcCtD
Methocarbamol—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00555	0.0056	CcSEcCtD
Methocarbamol—Vomiting—Progesterone—uterine cancer	0.0055	0.00555	CcSEcCtD
Methocarbamol—Rash—Progesterone—uterine cancer	0.00546	0.00551	CcSEcCtD
Methocarbamol—Dermatitis—Progesterone—uterine cancer	0.00545	0.0055	CcSEcCtD
Methocarbamol—Headache—Progesterone—uterine cancer	0.00542	0.00547	CcSEcCtD
Methocarbamol—Thrombophlebitis—Doxorubicin—uterine cancer	0.0054	0.00545	CcSEcCtD
Methocarbamol—Dysgeusia—Etoposide—uterine cancer	0.00531	0.00536	CcSEcCtD
Methocarbamol—Pain—Dactinomycin—uterine cancer	0.00523	0.00528	CcSEcCtD
Methocarbamol—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00519	0.00523	CcSEcCtD
Methocarbamol—Nausea—Progesterone—uterine cancer	0.00514	0.00519	CcSEcCtD
Methocarbamol—Diplopia—Epirubicin—uterine cancer	0.00505	0.0051	CcSEcCtD
Methocarbamol—Feeling abnormal—Dactinomycin—uterine cancer	0.00504	0.00509	CcSEcCtD
Methocarbamol—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00499	0.00503	CcSEcCtD
Methocarbamol—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00494	0.00499	CcSEcCtD
Methocarbamol—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00494	0.00499	CcSEcCtD
Methocarbamol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00491	0.00496	CcSEcCtD
Methocarbamol—Vertigo—Etoposide—uterine cancer	0.00487	0.00492	CcSEcCtD
Methocarbamol—Leukopenia—Etoposide—uterine cancer	0.00486	0.0049	CcSEcCtD
Methocarbamol—Body temperature increased—Dactinomycin—uterine cancer	0.00484	0.00488	CcSEcCtD
Methocarbamol—Loss of consciousness—Etoposide—uterine cancer	0.00477	0.00481	CcSEcCtD
Methocarbamol—Convulsion—Etoposide—uterine cancer	0.0047	0.00474	CcSEcCtD
Methocarbamol—Diplopia—Doxorubicin—uterine cancer	0.00467	0.00472	CcSEcCtD
Methocarbamol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00466	0.0047	CcSEcCtD
Methocarbamol—Hypersensitivity—Dactinomycin—uterine cancer	0.00451	0.00455	CcSEcCtD
Methocarbamol—Confusional state—Etoposide—uterine cancer	0.00446	0.00451	CcSEcCtD
Methocarbamol—Anaphylactic shock—Etoposide—uterine cancer	0.00443	0.00447	CcSEcCtD
Methocarbamol—Hypotension—Etoposide—uterine cancer	0.00414	0.00418	CcSEcCtD
Methocarbamol—Somnolence—Etoposide—uterine cancer	0.00394	0.00397	CcSEcCtD
Methocarbamol—Drowsiness—Epirubicin—uterine cancer	0.00389	0.00393	CcSEcCtD
Methocarbamol—Vomiting—Dactinomycin—uterine cancer	0.00389	0.00393	CcSEcCtD
Methocarbamol—Rash—Dactinomycin—uterine cancer	0.00386	0.00389	CcSEcCtD
Methocarbamol—Jaundice—Epirubicin—uterine cancer	0.00379	0.00383	CcSEcCtD
Methocarbamol—Pain—Etoposide—uterine cancer	0.00379	0.00382	CcSEcCtD
Methocarbamol—Conjunctivitis—Epirubicin—uterine cancer	0.00378	0.00382	CcSEcCtD
Methocarbamol—Feeling abnormal—Etoposide—uterine cancer	0.00365	0.00368	CcSEcCtD
Methocarbamol—Nausea—Dactinomycin—uterine cancer	0.00363	0.00367	CcSEcCtD
Methocarbamol—Drowsiness—Doxorubicin—uterine cancer	0.0036	0.00363	CcSEcCtD
Methocarbamol—Bradycardia—Epirubicin—uterine cancer	0.00356	0.00359	CcSEcCtD
Methocarbamol—Urticaria—Etoposide—uterine cancer	0.00352	0.00355	CcSEcCtD
Methocarbamol—Jaundice—Doxorubicin—uterine cancer	0.00351	0.00354	CcSEcCtD
Methocarbamol—Body temperature increased—Etoposide—uterine cancer	0.0035	0.00353	CcSEcCtD
Methocarbamol—Conjunctivitis—Doxorubicin—uterine cancer	0.0035	0.00353	CcSEcCtD
Methocarbamol—Bradycardia—Doxorubicin—uterine cancer	0.00329	0.00332	CcSEcCtD
Methocarbamol—Hypersensitivity—Etoposide—uterine cancer	0.00326	0.00329	CcSEcCtD
Methocarbamol—Flushing—Epirubicin—uterine cancer	0.00324	0.00327	CcSEcCtD
Methocarbamol—Pruritus—Etoposide—uterine cancer	0.00313	0.00316	CcSEcCtD
Methocarbamol—Flushing—Doxorubicin—uterine cancer	0.003	0.00303	CcSEcCtD
Methocarbamol—Dysgeusia—Epirubicin—uterine cancer	0.00298	0.00301	CcSEcCtD
Methocarbamol—Dizziness—Etoposide—uterine cancer	0.00293	0.00295	CcSEcCtD
Methocarbamol—Vision blurred—Epirubicin—uterine cancer	0.00287	0.00289	CcSEcCtD
Methocarbamol—Vomiting—Etoposide—uterine cancer	0.00281	0.00284	CcSEcCtD
Methocarbamol—Rash—Etoposide—uterine cancer	0.00279	0.00282	CcSEcCtD
Methocarbamol—Dermatitis—Etoposide—uterine cancer	0.00279	0.00281	CcSEcCtD
Methocarbamol—Headache—Etoposide—uterine cancer	0.00277	0.0028	CcSEcCtD
Methocarbamol—Dysgeusia—Doxorubicin—uterine cancer	0.00275	0.00278	CcSEcCtD
Methocarbamol—Vertigo—Epirubicin—uterine cancer	0.00273	0.00276	CcSEcCtD
Methocarbamol—Syncope—Epirubicin—uterine cancer	0.00273	0.00275	CcSEcCtD
Methocarbamol—Leukopenia—Epirubicin—uterine cancer	0.00272	0.00275	CcSEcCtD
Methocarbamol—Loss of consciousness—Epirubicin—uterine cancer	0.00267	0.0027	CcSEcCtD
Methocarbamol—Vision blurred—Doxorubicin—uterine cancer	0.00265	0.00268	CcSEcCtD
Methocarbamol—Convulsion—Epirubicin—uterine cancer	0.00263	0.00266	CcSEcCtD
Methocarbamol—Nausea—Etoposide—uterine cancer	0.00263	0.00265	CcSEcCtD
Methocarbamol—Vertigo—Doxorubicin—uterine cancer	0.00253	0.00255	CcSEcCtD
Methocarbamol—Syncope—Doxorubicin—uterine cancer	0.00252	0.00255	CcSEcCtD
Methocarbamol—Leukopenia—Doxorubicin—uterine cancer	0.00252	0.00254	CcSEcCtD
Methocarbamol—Confusional state—Epirubicin—uterine cancer	0.0025	0.00253	CcSEcCtD
Methocarbamol—Anaphylactic shock—Epirubicin—uterine cancer	0.00248	0.0025	CcSEcCtD
Methocarbamol—Loss of consciousness—Doxorubicin—uterine cancer	0.00247	0.0025	CcSEcCtD
Methocarbamol—Shock—Epirubicin—uterine cancer	0.00244	0.00246	CcSEcCtD
Methocarbamol—Convulsion—Doxorubicin—uterine cancer	0.00244	0.00246	CcSEcCtD
Methocarbamol—Hypotension—Epirubicin—uterine cancer	0.00232	0.00234	CcSEcCtD
Methocarbamol—Confusional state—Doxorubicin—uterine cancer	0.00232	0.00234	CcSEcCtD
Methocarbamol—Anaphylactic shock—Doxorubicin—uterine cancer	0.0023	0.00232	CcSEcCtD
Methocarbamol—Shock—Doxorubicin—uterine cancer	0.00226	0.00228	CcSEcCtD
Methocarbamol—Insomnia—Epirubicin—uterine cancer	0.00224	0.00227	CcSEcCtD
Methocarbamol—Somnolence—Epirubicin—uterine cancer	0.00221	0.00223	CcSEcCtD
Methocarbamol—Dyspepsia—Epirubicin—uterine cancer	0.00218	0.0022	CcSEcCtD
Methocarbamol—Hypotension—Doxorubicin—uterine cancer	0.00215	0.00217	CcSEcCtD
Methocarbamol—Pain—Epirubicin—uterine cancer	0.00212	0.00214	CcSEcCtD
Methocarbamol—Insomnia—Doxorubicin—uterine cancer	0.00208	0.0021	CcSEcCtD
Methocarbamol—Feeling abnormal—Epirubicin—uterine cancer	0.00204	0.00206	CcSEcCtD
Methocarbamol—Somnolence—Doxorubicin—uterine cancer	0.00204	0.00206	CcSEcCtD
Methocarbamol—Dyspepsia—Doxorubicin—uterine cancer	0.00202	0.00204	CcSEcCtD
Methocarbamol—Urticaria—Epirubicin—uterine cancer	0.00197	0.00199	CcSEcCtD
Methocarbamol—Pain—Doxorubicin—uterine cancer	0.00196	0.00198	CcSEcCtD
Methocarbamol—Body temperature increased—Epirubicin—uterine cancer	0.00196	0.00198	CcSEcCtD
Methocarbamol—Feeling abnormal—Doxorubicin—uterine cancer	0.00189	0.00191	CcSEcCtD
Methocarbamol—Hypersensitivity—Epirubicin—uterine cancer	0.00183	0.00185	CcSEcCtD
Methocarbamol—Urticaria—Doxorubicin—uterine cancer	0.00182	0.00184	CcSEcCtD
Methocarbamol—Body temperature increased—Doxorubicin—uterine cancer	0.00182	0.00183	CcSEcCtD
Methocarbamol—Pruritus—Epirubicin—uterine cancer	0.00176	0.00177	CcSEcCtD
Methocarbamol—Hypersensitivity—Doxorubicin—uterine cancer	0.00169	0.00171	CcSEcCtD
Methocarbamol—Dizziness—Epirubicin—uterine cancer	0.00164	0.00166	CcSEcCtD
Methocarbamol—Pruritus—Doxorubicin—uterine cancer	0.00162	0.00164	CcSEcCtD
Methocarbamol—Vomiting—Epirubicin—uterine cancer	0.00158	0.00159	CcSEcCtD
Methocarbamol—Rash—Epirubicin—uterine cancer	0.00156	0.00158	CcSEcCtD
Methocarbamol—Dermatitis—Epirubicin—uterine cancer	0.00156	0.00158	CcSEcCtD
Methocarbamol—Headache—Epirubicin—uterine cancer	0.00155	0.00157	CcSEcCtD
Methocarbamol—Dizziness—Doxorubicin—uterine cancer	0.00152	0.00153	CcSEcCtD
Methocarbamol—Nausea—Epirubicin—uterine cancer	0.00147	0.00149	CcSEcCtD
Methocarbamol—Vomiting—Doxorubicin—uterine cancer	0.00146	0.00147	CcSEcCtD
Methocarbamol—Rash—Doxorubicin—uterine cancer	0.00145	0.00146	CcSEcCtD
Methocarbamol—Dermatitis—Doxorubicin—uterine cancer	0.00145	0.00146	CcSEcCtD
Methocarbamol—Headache—Doxorubicin—uterine cancer	0.00144	0.00145	CcSEcCtD
Methocarbamol—Nausea—Doxorubicin—uterine cancer	0.00136	0.00138	CcSEcCtD
